Sandoz scrambling to ramp up Canadian supplies; Judge approves J&J's $158M Texas settlement;

 @FiercePharma: Watson is close to a deal for Actavis, Bloomberg's sources say. Deal could be worth $6B. News | Follow @FiercePharma

> Sandoz's top official in Canada told government officials that his company is working "tirelessly" to reverse shortfalls of drugs caused by production problems at its Quebec plant. Story

> A Texas judge finalized the $158 million settlement between that state and Johnson & Johnson ($JNJ), ending a dispute over the company's marketing of the antipsychotic drug Risperdal; litigation with other states remains outstanding. Report

> FDA added new warnings about the risk of rare heart diseases to labeling on Forest Laboratories' ($FRX) Celexa and its generic copies. More

> Now that Seroquel's U.S. exclusivity has expired, Indian drugmakers including Sun Pharma, Dr Reddy's and Lupin have launched their versions of the antipsychotic drug. Report

> Standard & Poor's said that Bausch & Lomb's ($BOL) $500 million agreement to buy ISTA Pharmaceuticals ($ISTA) would not affect its credit ratings. Report

Biotech News

 @FierceBiotech: Moscow backs clones of Western biotech programs in Russia. Article | Follow @FierceBiotech

 @JohnCFierce: Merrimack Pharma is scaling back in hopes of finally pulling off an IPO. Now wants $100M. Persistent. Very persistent. More | Follow @JohnCFierce

 @RyanMFierce: Uh oh, Abbott, here come the Humira knockoff makers: More | Follow @RyanMFierce

@FierceMedDev: Biomet had previous run-in with feds | The Journal Gazette | Fort Wayne, IN. Item | Follow @FierceMedDev

> Affymax breaks Amgen's anemia drug monopoly with ESA approval. News

> Promethera Biosciences banks $31M to fund PhI/II stem cell trial. Story

> Amylin shares rocket up on report of $3.5B buyout offer by Bristol-Myers. News

> Novartis leads $12.5M A round for antibody diagnostics start-up ImaginAb. Article

> Conflicting signals cloud Chelsea's chances on D-Day for Northera. More

Drug Delivery News

> U Miami debuts bionanotech institute with drug delivery agenda. More

> DOD-funded project fuels inner ear drug delivery. Story

> Brazil's FBM Industria licenses Ampio's quick-dissolve premature-ejaculation pill. Article

> Supreme Court upholds Unigene's nasal delivery patent. News

Medical Device News

> FDA unveils guidance on how PMAs, de novo submissions are reviewed. News

> Strand Diagnostics to receive $30M from Soon-Shiong's NantWorks. Item

> Great Lakes NeuroTechnologies eyes DBS market for Parkinson's. More

> FDA unveils guidance on how PMAs, de novo submissions are reviewed. Article

> Consumer Reports blasts implant safety. Story

Biomarkers News

> The magnetic attraction of blood biomarkers. Article

> DiaGenic, GE combine genes and imaging for AD. Item

> Omics tests need validation. Commentary

> Brain atrophy links with tau biomarker in Alzheimer's progression. More

> Faulty genes may trigger early autistic brain growth. More

And Finally... Blocking a sugar produced by the human body could fight memory loss, scientists say. Report